1365-2982/asset/cover.gif?v=1&s=8457506954d7e64155ee5364e261c2ab6703595c "Neurogastroenterology & Motility")
E. Valdez-Morales and R. Guerrero-Alba contributed equally to the work.
1365-2982/asset/olbannerleft.jpg?v=1&s=3e6d8ce2ac034ad1307e3fe33dabe31e3066bbe7)
1365-2982/asset/olbannercenter.jpg?v=1&s=64df9bec0a4775d84e376c1bdfed34eaaafc9e5e)
1365-2982/asset/olbannerright.jpg?v=1&s=4a76424ffd9242654d7ac122068c2cb93e0562c3)
You have free access to this content
Release of endogenous opioids during a chronic IBD model suppresses the excitability of colonic DRG neurons
Article first published online: 10 SEP 2012
DOI: 10.1111/nmo.12008
© 2012 Blackwell Publishing Ltd
Additional Information
How to Cite
Valdez-Morales, E., Guerrero-Alba, R., Ochoa-Cortes, F., Benson, J., Spreadbury, I., Hurlbut, D., Miranda-Morales, M., Lomax, A. E. and Vanner, S. (2013), Release of endogenous opioids during a chronic IBD model suppresses the excitability of colonic DRG neurons. Neurogastroenterology & Motility, 25: 39–e4. doi: 10.1111/nmo.12008
- †
E. Valdez-Morales and R. Guerrero-Alba contributed equally to the work.
Publication History
- Issue published online: 20 DEC 2012
- Article first published online: 10 SEP 2012
- Received: 20 June 2012 Accepted for publication: 6 August 2012
References
- 1, . TNFalpha is a key mediator of the pronociceptive effects of mucosal supernatant from human ulcerative colitis on colonic DRG neurons. Gut 2010; 59: 612–21.
- 2, . Sensibility of the rectum to distension and the anorectal distension reflex in ulcerative colitis. Gut 1978; 19: 64–9.
- 3, , et al. Rectal afferent function in patients with inflammatory and functional intestinal disorders. Pain 1996; 66: 151–61.
- 4, , et al. Visceral pain perception is determined by the duration of colitis and associated neuropeptide expression in the mouse. Gut 2007; 56: 358–64.
- 5, . Opioid receptors and opioid peptide-producing leukocytes in inflammatory pain--basic and therapeutic aspects. Brain Behav Immun 2010; 24: 683–94.
- 6, , et al. Anti-inflammatory properties of the mu opioid receptor support its use in the treatment of colon inflammation. J Clin Invest 2003; 111: 1329–38.
- 7, , et al. Mu opioid receptor expression is increased in inflammatory bowel diseases: implications for homeostatic intestinal inflammation. Gut 2006; 55: 815–23.
- 8. Inflammatory bowel disease: etiology and pathogenesis. Gastroenterology 1998; 115: 182–205.
- 9, , et al. Infliximab for the treatment of fistulas in patients with Crohn’s disease. N Engl J Med 1999; 340: 1398–405.
- 10. Cytokines in intestinal inflammation: pathophysiological and clinical considerations. Gastroenterology 1994; 106: 533–9.
- 11, , et al. CD4+ T-cell modulation of visceral nociception in mice. Gastroenterology 2006; 130: 1721–8.
- 12, , , . TNBS ileitis evokes hyperexcitability and changes in ionic membrane properties of nociceptive DRG neurons. Am J Physiol Gastrointest Liver Physiol 2002; 282: G1045–51.
- 13, , . Ileitis modulates potassium and sodium currents in guinea pig dorsal root ganglia sensory neurons. J Physiol 2003; 3: 797–807.
- 14, . Inflammation-induced hyperexcitability of nociceptive gastrointestinal DRG neurones: the role of voltage-gated ion channels. Neurogastroenterol Motil 2005; 17: 175–86.
- 15, , . Characterization of six voltage-gated K+ currents in adult rat sensory neurons. J Neurophysiol 1996; 75: 2629–46.
- 16, . Increased excitability of afferent neurons innervating rat urinary bladder after chronic bladder inflammation. J Neurosci 1999; 19: 4644–53.
- 17, , et al. Proteinase-activated receptor-4 evoked colorectal analgesia in mice: an endogenously activated feed-back loop in visceral inflammatory pain. Neurogastroenterol Motil 2012; 24: 76–85, e13.
- 18, , , , . Protease-activated receptor-4 (PAR 4): a role as inhibitor of visceral pain and hypersensitivity. Neurogastroenterol Motil 2009; 21: 1189–e107.
- 19, , , , . Activation of protease-activated receptor-4 inhibits the intrinsic excitability of colonic dorsal root ganglia neurons. Neurogastroenterol Motil 2009; 21: 1218–21.
- 20
- 21, , . Cannabinoid CB2 receptors in the gastrointestinal tract: a regulatory system in states of inflammation. Br J Pharmacol 2008; 153: 263–70.
- 22, , , , , . Immune conditions associated with CD4+ T effector-induced opioid release and analgesia. Pain 2012; 153: 485–93.
- 23, , et al. Peripheral mechanisms of pain and analgesia. Brain Res Rev 2009; 60: 90–113.
- 24, , et al. Sensory denervation reduces visceral hypersensitivity in adult rats exposed to chronic unpredictable stress: evidences of neurogenic inflammation. Dig Dis Sci 2009; 54: 1884–91.
- 25, , , , , . Sensory neuron and substance P involvement in symptoms of a zymosan-induced rat model of acute bowel inflammation. Neuroscience 2007; 145: 699–707.
- 26, , , , , . Experimental colitis triggers the release of substance P and calcitonin gene-related peptide in the urinary bladder via TRPV1 signaling pathways. Exp Neurol 2010; 225: 262–73.
- 27, , et al. Sensory neuro-immune interactions differ between irritable bowel syndrome subtypes. Gut 2012; doi:10.1136/gutjnl-2011-301856.
- 28, . Prediction of repetitive firing behaviour from voltage clamp data on an isolated neurone soma. J Physiol 1971; 213: 31–53.
- 29, , et al. Chronic morphine use does not induce peripheral tolerance in a rat model of inflammatory pain. J Clin Invest 2008; 118: 1065–73.
- 30, , , , , . Ultra-low dose naloxone restores the antinociceptive effect of morphine in pertussis toxin-treated rats by reversing the coupling of mu-opioid receptors from Gs-protein to coupling to Gi-protein. Neuroscience 2009; 164: 435–43.
- 31, , , . Effects of kappa opioids in the inflamed rat colon. Pain 1999; 3: 175–85.
- 32, , , . Role of sensory neurons in colitis: increasing evidence for a neuroimmune link in the gut. Inflamm Bowel Dis 2011; 17: 1030–3.